|Dr Anthony Dear, ACBD|
Identification of a novel agent, able to inhibit neointimal hyperplasia through "epigenetic" mechanisms suggests a potential future treatment for this widespread problem.
Rahmatzadeh M, Liu HB, Krishna SM, Gaspari TA, Welungoda I, Widdop RE, Dear AE. A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia. Cardiovasc Drugs Ther. 2014 Jul 10. [Epub ahead of print] PMID: 25005755 [PubMed - as supplied by publisher]